KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Current Deferred Revenue (2017 - 2025)

Globus Medical (GMED) has disclosed Current Deferred Revenue for 9 consecutive years, with $36.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Current Deferred Revenue rose 66.67% year-over-year to $36.9 million, compared with a TTM value of $36.9 million through Dec 2025, up 66.67%, and an annual FY2025 reading of $36.9 million, up 66.67% over the prior year.
  • Current Deferred Revenue was $36.9 million for Q4 2025 at Globus Medical, up from $18.3 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $36.9 million in Q4 2025 and bottomed at $8.7 million in Q1 2021.
  • Average Current Deferred Revenue over 5 years is $16.6 million, with a median of $16.0 million recorded in 2023.
  • Peak annual rise in Current Deferred Revenue hit 66.67% in 2025, while the deepest fall reached 12.19% in 2025.
  • Year by year, Current Deferred Revenue stood at $12.0 million in 2021, then increased by 17.26% to $14.1 million in 2022, then soared by 30.28% to $18.4 million in 2023, then grew by 20.53% to $22.1 million in 2024, then surged by 66.67% to $36.9 million in 2025.
  • Business Quant data shows Current Deferred Revenue for GMED at $36.9 million in Q4 2025, $18.3 million in Q3 2025, and $24.0 million in Q2 2025.